Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAQ | Class A Ordinary Shares | Conversion of derivative security | +393K | 393K | Oct 19, 2023 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDAQ | Class B Ordinary Shares | Conversion of derivative security | $0 | -393K | -12.72% | $0.00 | 2.7M | Oct 19, 2023 | Class A Ordinary Shares | 393K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | The Class B Ordinary Shares are convertible, at the option of the holder, into Class A Ordinary Shares on a one-for-one basis, for no additional consideration, and have no expiration date. |
F2 | These shares are held directly by HCG Opportunity, LLC ("HCG Opportunity"). HCG Opportunity MM, LLC is the sole member of HCG Opportunity. Thomas D. Hennessy and Daniel J. Hennessy are the sole members of HCG Opportunity MM, LLC and serve on the Issuer's board of directors and report their beneficial ownership of the securities held directly by HCG Opportunity on separate Section 16 reports. Each of the reporting persons disclaims beneficial ownership of the shares reported herein except to the extent of its pecuniary interest therein. |